Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 2.95 AED
Change Today +0.08 / 2.79%
Volume 20.5K
As of 6:00 AM 04/23/15 All times are local (Market data is delayed by at least 15 minutes).

gulf pharmaceutical industri (JULPHAR) Snapshot

Open
2.95
Previous Close
2.87
Day High
2.95
Day Low
2.95
52 Week High
04/29/14 - 3.50
52 Week Low
04/5/15 - 2.70
Market Cap
3.0B
Average Volume 10 Days
352.1K
EPS TTM
0.24
Shares Outstanding
1.0B
EX-Date
05/7/15
P/E TM
12.3x
Dividend
0.15
Dividend Yield
3.08%
Current Stock Chart for GULF PHARMACEUTICAL INDUSTRI (JULPHAR)

Related News

No related news articles were found.

gulf pharmaceutical industri (JULPHAR) Related Businessweek News

No Related Businessweek News Found

gulf pharmaceutical industri (JULPHAR) Details

Gulf Pharmaceutical Industries P.S.C. manufactures and sells medicines, drugs, and other pharmaceutical and medical compounds in the United Arab Emirates and internationally. The company provides products that target various therapeutic segments, including antibiotics, biotech, cardiovascular, dermatology, GIT, insulin, metabolic, over the counter, paramedical, pulmonary, women’s health, and wound and burn. It also offers cosmetic compounds; wrapping and packing materials; and transportation services. The company was founded in 1980 and is based in Ras Al Khaimah, the United Arab Emirates.

Founded in 1980

gulf pharmaceutical industri (JULPHAR) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

gulf pharmaceutical industri (JULPHAR) Key Developments

Gulf Pharmaceutical Industries P.S.C. Announces Consolidated Earnings Results for the Year Ended 31 December 2014

Gulf Pharmaceutical Industries P.S.C. announced consolidated earnings results for the year ended 31 December 2014. For the year, the company reported sales was AED 1,442,257,000 against AED 1,362,071,000 a year ago. Profit for the year was AED 233,790,000 against AED 228,085,000 a year ago. Profit attributable to equity holders of the company was AED 235,289,000 against AED 230,361,000 a year ago. Basic earnings per share were 24 fils against 24 fils a year ago. Net cash generated from operating activities was AED 41,597,000 against AED 108,105,000 a year ago. Additions to property, plant and equipment was AED 81,178,000 against AED 91,658,000 a year ago.

Gulf Pharmaceutical Industries Reports Preliminary Earnings Results for the Year Ended December 31, 2014

Gulf Pharmaceutical Industries reported preliminary earnings results for the year ended December 31, 2014. For the period, the company reported revenue of AED 1,433,109,000 against AED 1,362,071,000 a year ago. Net operating profit was AED 238,473,000 against AED 235,839,000 a year ago. Net profit was AED 234,678,000 or AED 24 earnings per share against AED 228,085,000 or AED 27 earnings per share a year ago.

Gulf Pharmaceutical Industries P.S.C., Board Meeting, Dec 11, 2014

Gulf Pharmaceutical Industries P.S.C., Board Meeting, Dec 11, 2014., at 10:30 Indian Standard Time. Agenda: To approve the minutes of board meeting 5/2014; to consider the proposal of 2015 budget; to review of the proposal of issuance convertible bonds into shares that will be allocated to excellent employees and locales of the company amounting to AED 10 million to AED 20 million; and to consider any new business.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
JULPHAR:UH 2.95 AED +0.08

JULPHAR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for JULPHAR.
View Industry Companies
 

Industry Analysis

JULPHAR

Industry Average

Valuation JULPHAR Industry Range
Price/Earnings 12.2x
Price/Sales 2.0x
Price/Book 1.4x
Price/Cash Flow 12.5x
TEV/Sales 1.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GULF PHARMACEUTICAL INDUSTRI, please visit www.julphar.net. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.